Abstract Through the fluorescence and ultravioletvisible spectrophotometry we have studied the action of cefoperazone sodium and worfloxacin, two kinds of medicine with albumin, and examined the equal efficiency quality of fluorescence enhancement and fluorescence quenching equation. The result shows the equal efficiency of calculating dissociation constant. In this article, we obtain the dissociation constants of the action of the two kinds of medicine with bovine serum albumin, energy-transfer efficiency, the distance of donor-acceptor and quenching constants. The above shows that the action is not caused by dynamic collision but by the binding of medicine and albumin. This article specially points out that the [M t ]/[P t ], which is the ratio of the maximum mol concentration of the quenching agent (medicine) to fluorescent (albumin) mol concentration when the quenching ends, is very important because it is the maximum binding number of quenching agent molecule to a fluorescent molecule. There is no more quenching after adding more quenching agent beyond this quantity to fluorescent solution. This quantity is determined directly and strictly by experiment, so is also of important significance when discussing quenching efficiency and binding situation of donor-acceptor.
The interaction of little dynamic biological molecule with biomacromolecule is a basic problem of chemicobiology medicine chemistry and many other subjects. To the corresponding liquid system, because of single crystal diffraction's incapability and NMR spectroscopy's complexity, chemists usually like to study the interaction of medicine or metallic ions with biomacromolecules by fluorescence probe method that is relatively simple.
About fluorescence probe method, a few years ago we had deduced a new equation respectively from fluorescence enhancement [1] and fluorescence quenching [2] , which was broadly quoted by colleages [3 8] . Ten years' experience [9 17] made us think whether it is possible to regard fluorescence quenching as a negative fluorescence enhancement or not. To this kind of phenomenon such as quenching, can we get the two kinds of theories dually dealt with and the same or similar (because of the difference of supposition in the deduction of the two theories) result? In this article, we select cefoperazone sodium of cephalosporin class and worfloxacin sodium to act with BSA as an example, and then examine the equal-efficiency of fluorescence quenching and enhancement equation. Finally we have studied their quenching effect.
Experimental

Reagent
Bovine serum albumin (BSA), Shanghai Chemical Reagent Providing Station; cefoperazone sodium (pure powder), Zhongnuo Medical Limited Corporation; and worfloxacin sodium (pure powder), Henan Huaxin Pharmaceutical Factory. Other reagents are all made in China, AR. Fluorescence quenching of medicine to BSA is determined with Japan Shimadzu RF-540 fluorospectrophotometer, compared with that of Tris-HCl buffer solution, quartz cell is 1 cm excitation wavelength is fixed at 280 nm, and scan range of emission spectrum is 290 500 nm. We have determined fluorescence emission spectrum of BSA, and the absorption lines with Japan Shimadzu UV-265 spectrophotometer when medicine albumin=1 1 (mol ratio) in 290 500 nm.
Principle
2.1 Fluorescence enhancement effect [1] When biomarromolecules co-exist with some ligands, we can observe the obvious change of fluorescence intensity, which can be used to study the binding situation of biomarcromolecules and ligands. Supposing biomarcromolecule P binds with ligand M, and there are n same and separating binding sites, we have the following reaction
We can obtain . According to the above, we can get a figure, then obtain formation constant K A and binding sites n through the slope. [2] We can also study the action of medicine ligand and biomarcromolecule from the point of view of fluorescence quenching. When the fluorescent molecule acts on other molecule to cause the decrease of fluorescence strength, it is called fluorescence quenching which includes the dynamic and static quenching. For the static quenching, the relation between fluorescence strength and quenching medium can be deduced by the binding constant formula between fluorescent and quenching agent. Supposing that the biomarcromolecule has a few same and separating binding sites, we have the following reaction Supposing resultant Q n P does not emit light, it can be deduced:
Fluorescence quenching effect
[Q] is the concentration of quenching agent, F 0 and F are the fluorescence intensity of free biomarcromolecule and that after adding quenching agent. The double reciprocal curve can be made for (
Result
Dissociation constant and quenching constant of medicine acting with BSA by fluorescence quenching formula
It is determined that fluorescence intensity of medicine is near zero, free BSA has strong fluorescence at 330 nm with the titrated medicine, and the fluorescence of BSA gradually quenches. Its quenching process is shown in Fig.  1 , and then the double reciprocal curve is made using eq. (5) and good line as Fig. 2 can be got. From Fig. 2 the dissociation constant and linear interrelation coefficient of the two kinds of medicine acting with BSA can be got (Table 1) .
First, we can see from quenching curve ( Fig. 1 ) that quenching curve of worfloxacin is a good straight line in the low concentration range where the ratio of medicine/albumin is less than 4. In the range, the quenching of worfloxacin to BSA is static quenching. There is a turning point when the ratio of medicine/albumin is 4. Above the turning point, the slope of the line increases. This shows that the albumin has two kinds of binding sites of worfloxacin, one can only bind 4 medicine molecules, and the other can bind more medicine molecules. The quenching curve of cefoperazone sodium can also be regarded as a straight line in low concentration (the ratio under 10). When the concentration is higher, the curve turns up, but there is no turning point. So it is static quenching in low concentration. Second, we can see that the static quenching equation (5) is similar to stern-Volmer collision quenching equation [17] :
, and combining the two equations, we get
in which, the fluorescence life span of the biomarcromolecule τ 0 is 10 ns [18] , from K D of Table 1 we can get apparent quenching constant K q of the two medicine (Table 1). It is known that the biggest diffusion collision quenching constant of any kind of quenching agent to biomarcromolecule is [17] . We can see from the data of the table that the apparent quenching constant K q of medicine to albumin is much bigger than diffusion-controlled quenching constant. It shows that the quenching of medicine to albumin is not caused by dynamic collision. It can be seen from the quenching constant K q and [M t ]/[P t ] of Fig. 1 and Table 1 that the quenching efficiency of cefoperazone to albumin is five times lower than worfloxacin. Third, we can see from dipole-dipole non-radiation energy transition that because the distance between donoracceptor (medicine-albumin tryptophan residue) is 3.47 nm for worfloxacin, but 4.18 nm for cefoperazone, the non-radiation energy transition efficiency E of which is 3 times lower than that of worfloxacin, and fluorescence quenching of corresponding concentration of albumin can be only caused by adding more cefoperazone.
From the deduced eqs. (1) and (4) and long-term study, we think that this kind of quenching is related to the binding of medicine with albumin, and the binding sites in the albumin. So the fluorescence quenching of the medicine listed in Table 1 to the albumin is mainly caused by static quenching and dipole-dipole non-radiation energy transition, that is to say, by the binding of medicine and albumin.
3.2 The distance between fluorescence donor-acceptor [17, 18] According to Forster-type dipole-dipole non-radiation energy-transferring mechanism, the transferring efficiency is related to the distance r between the donor and acceptor and the distance R 0 of the critical energy transferring 6 0 6 6 0 , ( )
where R 0 is the critical distance when the transferring efficiency is 50%, 2 is the directional factor of dipole space, n is the refraction index of the medium, φ is the fluorescence quenching yield of the donor, J is the spectrum overlap integration between the fluorescence emission spectrum of donor and the absorption spectrum of acceptor, which can be expressed as
where F D ( ν ) is the fluorescence strength of donor at the wave number ν , ε A (õ) is the mol extinction coefficient of acceptor at wave number ν . Energy-transferring efficiency E can be determined by
Obvious, if we know E, K 2 , φ and n, and evaluate the integral J from the experimental spectra, we can obtain R 0 and r. By using the lately determined fluorescence emission spectrum of albumin and the absorption spectrum when the mol ratio of albumin to medicine is 1:1, according to the method in ref. [1] we can calculate and obtain J, R , E, r ( Table 1) . By choosing the data of 3.1 and using eq. (3) we can make the double reciprocal curve and still get good straight line (Fig. 3) , from which we can calculate the dissociation constants and linear interrelation coefficients (Table 2) .
Discussion and conclusion
Comparing Fig. 2 with Fig. 3 , based on fluorescence quenching equation (6) , the linear interrelation coefficient C of cefoperazone s odium is 0.9996. While based on fluorescence quenching equation (6) C is 0.9990. Comparing Table 1 with Table 2 Until now what confuses us is the binding site n. There is n in both fundamental equations (1) and (4) deduced from the fluorescence enhancement and quenching theory, but in the process of deducing the fluorescence quenching equation the n is eliminated, so in the final equation there is no n. There is n in the final equation of fluorescence enhancement effect, but in practice n is a changable parameter that is sometimes sensitive. So in some condition it is wanton. This is caused by the complexity of fluorescence quenching mechanism and limit of spectrum method. The [M t ]/[P t ], which is always neglected, is the ratio of the maximum mol concentration of the quenching agent (the medicine in our article) to fluorescent mol concentration when the quenching ends. Whatever quenching mechanism in it is, this quantity is very important, because it is the maximum binding number of quenching agent molecule to a fluorescent molecule. There is no more quenching after adding more quenching agent beyond this quantity to fluorescent solution. This quantity is determined directly and strictly by experiment, so it is also worthy of stress when discussing quenching efficiency and binding situation of donor-acceptor.
